Clinical Trial

Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 11, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
A study to evaluate the impact of nephrotic syndrome on the steady state pharmacokinetics and pharmacodynamics of edoxaban compared to health volunteers, and whether edoxaban can provide an equivalent anticoagulant effect to enoxaparin sodium.
Trial Details
NCT Number NCT07116239
Lead Sponsor Peking University People's Hospital
Collaborators: Chinese Academy of Medical Sciences, Fuwai Hospital
Conditions Nephrotic Syndrome, Hypoalbuminemia
Enrollment 60 participants
Start Date 2025-09
Primary Completion 2026-02 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-08-11